Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery

Autor: Tsutomu Fujii, Hiroki Yamaue, Yatsuka Sahara, Yoshiaki Murakami, Sohei Satoi, Tetsuo Ohta, Shigeyuki Kawachi, Yosuke Hijikata, Shuji Isaji, Shuji Suzuki, Masayuki Sho, Yuichi Hosokawa, Kenji Katsumata, Itaru Endo, Yuichi Nagakawa, Akihiko Tsuchida, Michiaki Unno, Chie Takishita, Takukazu Nagakawa
Rok vydání: 2019
Předmět:
Zdroj: Annals of Surgical Oncology. 26:1629-1636
ISSN: 1534-4681
1068-9265
DOI: 10.1245/s10434-018-07131-8
Popis: The efficacy of neoadjuvant therapy (NAT), including neoadjuvant chemotherapy (NAC) and neoadjuvant chemo-radiotherapy (NACRT), for patients with borderline resectable pancreatic cancer (BRPC) has not been elucidated. This study aimed to clarify the efficacy of NAC and NACRT for patients with BRPC. The study analyzed the treatment outcomes of 884 patients treated for BRPC from 2011 to 2013. Treatment results were compared between upfront surgery and NAT and between NAC and NACRT using propensity score-matching analysis. Overall survival (OS) was calculated via intention-to-treat analyses. The overall resection rates for the patients who underwent NAT were significantly lower than for the patients who underwent upfront surgery (75.1% vs 93.3%; p
Databáze: OpenAIRE